• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用点击化学——基于活性的蛋白质谱法对 2-硫代黄嘌呤髓过氧化物酶抑制剂的机制特征分析和选择性评估

Mechanistic characterization of a 2-thioxanthine myeloperoxidase inhibitor and selectivity assessment utilizing click chemistry--activity-based protein profiling.

机构信息

Cardiovascular and Metabolic Diseases Research Unit and ‡Medicinal Chemistry, Pfizer Worldwide Research and Development , Cambridge, Massachusetts 02139, United States.

出版信息

Biochemistry. 2013 Dec 23;52(51):9187-201. doi: 10.1021/bi401354d. Epub 2013 Dec 9.

DOI:10.1021/bi401354d
PMID:24320749
Abstract

Myeloperoxidase (MPO) is a heme peroxidase that catalyzes the production of hypochlorous acid. Despite a high level of interest in MPO as a therapeutic target, there have been limited reports about MPO inhibitors that are suitable for evaluating MPO in pharmacological studies. 2-Thioxanthine, 3-(2-ethoxypropyl)-2-thioxo-2,3-dihydro-1H-purin-6(9H)-one (A), has recently been reported to inhibit MPO by covalently modifying the heme prosthetic group. Here we report a detailed mechanistic characterization demonstrating that A possesses all the distinguishing features of a mechanism-based inactivator. A is a time-dependent MPO inhibitor and displays saturable inactivation kinetics consistent with a two-step mechanism of inactivation and a potency (k(inact)/K(I) ratio) of 8450 ± 780 M⁻¹ s⁻¹. MPO inactivation by A is dependent on MPO catalysis and is protected by substrate. A reduces MPO compound I to compound II with a second-order rate constant of (0.801 ± 0.056) × 10⁶ M⁻¹ s⁻¹, and its irreversible inactivation of MPO occurs prior to release of the activated inhibitory species. Despite its relatively high selectivity against a broad panel of more than 100 individual targets, including enzymes, receptors, transporters, and ion channels, we demonstrate that A labels multiple other protein targets in the presence of MPO. By synthesizing an alkyne analogue of A and utilizing click chemistry-activity-based protein profiling, we present that the MPO-activated inhibitory species can diffuse away to covalently modify other proteins, as reflected by the relatively high partition ratio of A, which we determined to be 15.6. This study highlights critical methods that can guide the discovery and development of next-generation MPO inhibitors.

摘要

髓过氧化物酶 (MPO) 是一种血红素过氧化物酶,可催化次氯酸的生成。尽管人们对 MPO 作为治疗靶点非常感兴趣,但关于适合用于评估药理学研究中 MPO 的 MPO 抑制剂的报道却很少。2-硫代嘌呤,3-(2-乙氧基丙基)-2-硫代-2,3-二氢-1H-嘌呤-6(9H)-酮(A),最近有报道称其通过共价修饰血红素辅基来抑制 MPO。在这里,我们报告了一项详细的机制特征描述,证明 A 具有所有特征,是一种基于机制的失活剂。A 是一种时间依赖性的 MPO 抑制剂,表现出饱和失活动力学,与两步失活机制一致,效力(k(inact)/K(I) 比值)为 8450 ± 780 M⁻¹ s⁻¹。A 对 MPO 的失活依赖于 MPO 催化,且受底物保护。A 将 MPO 化合物 I 还原为化合物 II 的二级速率常数为(0.801 ± 0.056)× 10⁶ M⁻¹ s⁻¹,其对 MPO 的不可逆失活发生在激活的抑制性物质释放之前。尽管 A 对包括酶、受体、转运体和离子通道在内的 100 多种单个靶标具有相对较高的选择性,但我们证明在 MPO 存在的情况下,A 可标记其他多个蛋白质靶标。通过合成 A 的炔类似物并利用点击化学-活性蛋白质谱分析,我们发现 MPO 激活的抑制性物质可以扩散并与其他蛋白质发生共价修饰,这反映了 A 的相对较高的分配比,我们确定该分配比为 15.6。这项研究突出了可以指导下一代 MPO 抑制剂的发现和开发的关键方法。

相似文献

1
Mechanistic characterization of a 2-thioxanthine myeloperoxidase inhibitor and selectivity assessment utilizing click chemistry--activity-based protein profiling.利用点击化学——基于活性的蛋白质谱法对 2-硫代黄嘌呤髓过氧化物酶抑制剂的机制特征分析和选择性评估
Biochemistry. 2013 Dec 23;52(51):9187-201. doi: 10.1021/bi401354d. Epub 2013 Dec 9.
2
Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases.2-(6-(5-氯-2-甲氧基苯基)-4-氧代-2-硫代-3,4-二氢嘧啶-1(2H)-基)乙酰胺(PF-06282999)的发现:一种基于机制的高选择性髓过氧化物酶抑制剂用于治疗心血管疾病。
J Med Chem. 2015 Nov 12;58(21):8513-28. doi: 10.1021/acs.jmedchem.5b00963. Epub 2015 Oct 28.
3
Ordered cleavage of myeloperoxidase ester bonds releases active site heme leading to inactivation of myeloperoxidase by benzoic acid hydrazide analogs.苯甲酰肼类似物通过有序切割髓过氧化物酶酯键释放活性部位血红素,导致髓过氧化物酶失活。
Arch Biochem Biophys. 2014 Apr 15;548:74-85. doi: 10.1016/j.abb.2014.02.014. Epub 2014 Mar 13.
4
Novel bis-arylalkylamines as myeloperoxidase inhibitors: Design, synthesis, and structure-activity relationship study.新型双芳基烷基胺作为髓过氧化物酶抑制剂的设计、合成及构效关系研究。
Eur J Med Chem. 2016 Nov 10;123:746-762. doi: 10.1016/j.ejmech.2016.07.053. Epub 2016 Jul 25.
5
Inactivation of human myeloperoxidase by hydrogen peroxide.人髓过氧化物酶的过氧化氢失活。
Arch Biochem Biophys. 2013 Nov 1;539(1):51-62. doi: 10.1016/j.abb.2013.09.004. Epub 2013 Sep 11.
6
Regulation of the nitric oxide oxidase activity of myeloperoxidase by pharmacological agents.药物对髓过氧化物酶一氧化氮氧化酶活性的调节。
Biochem Pharmacol. 2017 Jul 1;135:90-115. doi: 10.1016/j.bcp.2017.03.016. Epub 2017 Mar 24.
7
Inactivation of myeloperoxidase by benzoic acid hydrazide.苯甲酸酰肼对髓过氧化物酶的失活作用。
Arch Biochem Biophys. 2015 Mar 15;570:14-22. doi: 10.1016/j.abb.2015.01.028. Epub 2015 Feb 14.
8
The soluble curcumin derivative NDS27 inhibits superoxide anion production by neutrophils and acts as substrate and reversible inhibitor of myeloperoxidase.可溶性姜黄素衍生物 NDS27 可抑制中性粒细胞超氧阴离子的产生,并作为髓过氧化物酶的底物和可逆抑制剂。
Chem Biol Interact. 2019 Jan 5;297:34-43. doi: 10.1016/j.cbi.2018.10.008. Epub 2018 Oct 18.
9
Analysis of the mechanism by which tryptophan analogs inhibit human myeloperoxidase.色氨酸类似物抑制人髓过氧化物酶的机制分析。
Free Radic Biol Med. 2009 Oct 1;47(7):1005-13. doi: 10.1016/j.freeradbiomed.2009.07.007. Epub 2009 Jul 25.
10
Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design.在抑制剂设计中对人髓过氧化物酶异常热力学性质的利用。
Biochem Pharmacol. 2005 Apr 15;69(8):1149-57. doi: 10.1016/j.bcp.2005.02.006.

引用本文的文献

1
Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory disease.在炎症性疾病临床前模型中,用双抑制剂SNT-8370靶向血管黏附蛋白-1和髓过氧化物酶。
Nat Commun. 2025 Apr 11;16(1):3430. doi: 10.1038/s41467-025-58454-6.
2
Environment-sensitive turn-on fluorescent probe enables live cell imaging of myeloperoxidase activity during NETosis.环境敏感型开启式荧光探针可实现对中性粒细胞胞外诱捕网形成过程中髓过氧化物酶活性的活细胞成像。
Commun Chem. 2024 Nov 12;7(1):262. doi: 10.1038/s42004-024-01338-5.
3
Role of Myeloperoxidase, Oxidative Stress, and Inflammation in Bronchopulmonary Dysplasia.
髓过氧化物酶、氧化应激和炎症在支气管肺发育不良中的作用
Antioxidants (Basel). 2024 Jul 23;13(8):889. doi: 10.3390/antiox13080889.
4
Targeting Myeloperoxidase Ameliorates Gouty Arthritis: A Virtual Screening Success Story.靶向髓过氧化物酶治疗痛风性关节炎:虚拟筛选的成功案例。
J Med Chem. 2024 Jul 25;67(14):12012-12032. doi: 10.1021/acs.jmedchem.4c00721. Epub 2024 Jul 11.
5
Myeloperoxidase: a new target for the treatment of stroke?髓过氧化物酶:中风治疗的新靶点?
Neural Regen Res. 2022 Aug;17(8):1711-1716. doi: 10.4103/1673-5374.332130.
6
29th Annual GP2A Medicinal Chemistry Conference.第29届年度GP2A药物化学会议。
Pharmaceuticals (Basel). 2021 Dec 7;14(12):1278. doi: 10.3390/ph14121278.
7
Activity-Based Protein Profiling (ABPP) of Oxidoreductases.基于活性的氧化还原酶蛋白质谱分析(ABPP)。
Chembiochem. 2021 Feb 15;22(4):630-638. doi: 10.1002/cbic.202000542. Epub 2020 Oct 20.
8
Potent Triazolopyridine Myeloperoxidase Inhibitors.强效三唑并吡啶髓过氧化物酶抑制剂
ACS Med Chem Lett. 2018 Nov 1;9(12):1175-1180. doi: 10.1021/acsmedchemlett.8b00308. eCollection 2018 Dec 13.
9
Triazolopyrimidines identified as reversible myeloperoxidase inhibitors.被鉴定为可逆性髓过氧化物酶抑制剂的三唑并嘧啶类化合物。
Medchemcomm. 2017 Oct 26;8(11):2093-2099. doi: 10.1039/c7md00268h. eCollection 2017 Nov 1.
10
Myeloperoxidase Inhibition Increases Neurogenesis after Ischemic Stroke.髓过氧化物酶抑制可增加缺血性中风后的神经发生。
J Pharmacol Exp Ther. 2016 Nov;359(2):262-272. doi: 10.1124/jpet.116.235127. Epub 2016 Aug 22.